First Manhattan’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,000
| Closed | -$2.68K | – | 860 |
|
|
2024
Q1 | $2.68K | Buy |
+1,000
| New | +$2.68K | ﹤0.01% | 1264 |
|
|
2022
Q4 | – | Sell |
-340
| Closed | -$2K | – | 1721 |
|
|
2022
Q3 | $2K | Sell |
340
-70
| -17% | -$412 | ﹤0.01% | 1415 |
|
|
2022
Q2 | $2K | Hold |
410
| – | – | ﹤0.01% | 1427 |
|
|
2022
Q1 | $1K | Hold |
410
| – | – | ﹤0.01% | 1530 |
|
|
2021
Q4 | $2K | Hold |
410
| – | – | ﹤0.01% | 1470 |
|
|
2021
Q3 | $4K | Hold |
410
| – | – | ﹤0.01% | 1424 |
|
|
2021
Q2 | $8K | Hold |
410
| – | – | ﹤0.01% | 1311 |
|
|
2021
Q1 | $11K | Hold |
410
| – | – | ﹤0.01% | 1216 |
|
|
2020
Q4 | $10K | Hold |
410
| – | – | ﹤0.01% | 1145 |
|
|
2020
Q3 | $15K | Hold |
410
| – | – | ﹤0.01% | 1070 |
|
|
2020
Q2 | $21K | Hold |
410
| – | – | ﹤0.01% | 1020 |
|
|
2020
Q1 | $12K | Buy |
+410
| New | +$12K | ﹤0.01% | 1102 |
|